Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
787
+111
+16% +$39.6K 0.02% 75
2025
Q4
$221K Sell
676
-348
-34% -$110K 0.02% 74
2025
Q3
$289K Hold
1,024
0.02% 85
2025
Q2
$286K Sell
1,024
-8
-0.8% -$2.27K 0.02% 82
2025
Q1
$322K Buy
1,032
+2
+0.2% +$591 0.03% 82
2024
Q4
$268K Sell
1,030
-12
-1% -$3.56K 0.02% 88
2024
Q3
$336K Buy
1,042
+1
+0.1% +$327 0.03% 80
2024
Q2
$325K Sell
1,041
-75
-7% -$22K 0.03% 79
2024
Q1
$317K Buy
1,116
+186
+20% +$54.4K 0.03% 86
2023
Q4
$268K Buy
+930
New +$253K 0.03% 77
2020
Q1
Sell
-842
Closed -$203K 73
2019
Q4
$203K Buy
+842
New +$186K 0.03% 78

Other funds holding AMGN

McDaniel Terry & Co's AMGN Position: Q1 2026 in Review

McDaniel Terry & Co increased its Amgen (AMGN) stake by 16% in Q1 2026, buying an estimated $39.6K and bringing the position to 787 shares worth $277K. The position accounts for 0.02% of the portfolio, ranked #75.

McDaniel Terry & Co first reported a position in AMGN in Q4 2019 and has held it in 11 quarters since. The position peaked at $336K in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • McDaniel Terry & Co held 787 shares of Amgen worth $277K as of Q1 2026.
  • McDaniel Terry & Co bought 111 Amgen shares in Q1 2026, an estimated $39.6K.
  • Amgen made up 0.02% of McDaniel Terry & Co's portfolio in Q1 2026, its #75 holding.
  • McDaniel Terry & Co first reported a position in Amgen in Q4 2019 and has held it in 11 quarters since.
  • McDaniel Terry & Co's Amgen position peaked at $336K in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on McDaniel Terry & Co's 13F filing for Q1 2026, filed 5 May 2026.